Fair Value Measurements (Tables)

6 Months Ended

Sep. 30, 2017

Fair value of assets and liabilities on a recurring basis

The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at September 30, 2017 and March 31, 2017:



	Balance at		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
	September 30, 2017				Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
ASSETS
Cash and cash equivalents⁽¹⁾	$	26,553	$	26,553	$	—	$	—
Restricted cash and cash equivalents	6,488		6,488		—		—
	$	33,041	$	33,041	$	—	$	—



	Balance at		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
	March 31, 2017				Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
ASSETS
Cash and cash equivalents ⁽¹⁾	$	37,673	$	37,673	$	—	$	—
Restricted cash and cash equivalents	4,916		4,916		—		—
	$	42,589	$	42,589	$	—	$	—
LIABILITIES
Contingent consideration related to acquisitions ⁽²⁾	$	18,817	$	—	$	18,817	$	—
	$	18,817	$	—	$	18,817	$	—

___________________________________

⁽¹⁾ Cash equivalents consist primarily of money market funds.

⁽²⁾ The contingent consideration liability as of March 31, 2017 relates to the acquisition of HealthFusion, which was settled during the quarter ended June 30, 2017. The measurement period of the contingent consideration liability ended on December 31, 2016, and thus the actual revenue achievement rate was utilized to compute the ending contingent consideration liability as of March 31, 2017. Accordingly, the contingent consideration liability was reflected under a Level 2 valuation hierarchy because the fair value was determined based on other significant observable inputs.